Using cell mass to determine response to treatment: A possible cure?
What are the benefits of having different chronic lymphocytic leukemia (CLL) treatment options?
Acute leukemias discussion: what does genomics and epigenomics tell us about patient management?
Ari Melnick et al.
Determining the progression of SMM using predictive biomarkers
Understanding the genetic risks of CLL